Evaluation of the efficacy of extended-release buprenorphine (Ethiqa XR) using objective gait analysis in dogs

Objective To evaluate the efficacy of an extended-release formulation of buprenorphine HCl (XR-Bup) using objective gait analysis in a canine stifle arthrotomy model. We hypothesized that a single SC injection of XR-Bup would reduce postoperative pain and improve limb function. Methods In a randomized, blinded, placebo-controlled crossover study design, 8 purpose-bred Beagles underwent 2 unilateral stifle arthrotomies, randomized to XR-Bup for 1 procedure and placebo for the other, separated by a washout period. Kinetic and static ground reaction force data were collected at baseline (pretreatment) and multiple time points up to 72 hours after arthrotomy. Symmetry indices were calculated for ground reaction force variables and compared between groups using a repeated-measures analysis. Results Overall, symmetry indices of static body weight distribution (%BW distrib ) showed significantly greater limb use symmetry following XR-Bup compared to placebo. There was significant time and treatment interaction ( P = .025) for %BW distrib to the operated limb, with %BW distrib approaching baseline levels more quickly when treated with XR-Bup. Similarly, kinetic variables demonstrated higher limb use in the XR-Bup group, although the treatment effects were not significant. All dogs experienced nausea and hyporexia/anorexia after XR-Bup over 72 hours. Vomiting occurred in 6 of 9 and regurgitation was observed in 8 of 9 arthrotomy cases. Conclusions XR-Bup treatment was associated with greater limb usage (static and dynamic) at all time points, with data indicating effective pain alleviation in a small cohort of dogs. Clinical Relevance Although Ethiqa XR may be an alternative option for postoperative pain control, its clinical utility at the dose evaluated in this study may be limited by the occurrence of adverse events.

Authors

Institutions

Publication Details

Journal
American Journal of Veterinary Research
Published
2026-11-19
DOI
https://doi.org/10.2460/ajvr.26.08.0345
Primary Topic
Veterinary Pharmacology and Anesthesia
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Evaluation of the efficacy of extended-release buprenorphine (Ethiqa XR) using objective gait analysis in dogs

Benedict Duncan X. Lascelles, Nathan P. Hall, Kim R. Love, Santosh Kumar Mishra et al.
American Journal of Veterinary Research
Veterinary Pharmacology and Anesthesia
article

Evaluation of the efficacy of extended-release buprenorphine (Ethiqa XR) using objective gait analysis in dogs

Benedict Duncan X. Lascelles, Nathan P. Hall, Kim R. Love, Santosh Kumar Mishra, Javier Benito, Hiroko Enomoto, Masataka Enomoto, Kornelia Tiffinger, Amber Hall, Reece Taylor
article en

Abstract

Objective To evaluate the efficacy of an extended-release formulation of buprenorphine HCl (XR-Bup) using objective gait analysis in a canine stifle arthrotomy model. We hypothesized that a single SC injection of XR-Bup would reduce postoperative pain and improve limb function. Methods In a randomized, blinded, placebo-controlled crossover study design, 8 purpose-bred Beagles underwent 2 unilateral stifle arthrotomies, randomized to XR-Bup for 1 procedure and placebo for the other, separated by a washout period. Kinetic and static ground reaction force data were collected at baseline (pretreatment) and multiple time points up to 72 hours after arthrotomy. Symmetry indices were calculated for ground reaction force variables and compared between groups using a repeated-measures analysis. Results Overall, symmetry indices of static body weight distribution (%BW distrib ) showed significantly greater limb use symmetry following XR-Bup compared to placebo. There was significant time and treatment interaction ( P = .025) for %BW distrib to the operated limb, with %BW distrib approaching baseline levels more quickly when treated with XR-Bup. Similarly, kinetic variables demonstrated higher limb use in the XR-Bup group, although the treatment effects were not significant. All dogs experienced nausea and hyporexia/anorexia after XR-Bup over 72 hours. Vomiting occurred in 6 of 9 and regurgitation was observed in 8 of 9 arthrotomy cases. Conclusions XR-Bup treatment was associated with greater limb usage (static and dynamic) at all time points, with data indicating effective pain alleviation in a small cohort of dogs. Clinical Relevance Although Ethiqa XR may be an alternative option for postoperative pain control, its clinical utility at the dose evaluated in this study may be limited by the occurrence of adverse events.

American Journal of Veterinary Research
University of North Carolina at Chapel Hill (US), North Carolina State University (US), Duke University (US)
Veterinary Pharmacology and Anesthesia
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon